BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30693431)

  • 1. Perspectives on the Role of Mathematics in Drug Discovery and Development.
    Allen R; Moore H
    Bull Math Biol; 2019 Sep; 81(9):3425-3435. PubMed ID: 30693431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparing for a career in biopharma research.
    Wu LC
    Trends Immunol; 2015 May; 36(5):290-2. PubMed ID: 25804896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Can Mathematics Do for Drug Development?
    Moore H; Allen R
    Bull Math Biol; 2019 Sep; 81(9):3421-3424. PubMed ID: 31332601
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond Deterministic Models in Drug Discovery and Development.
    Irurzun-Arana I; Rackauckas C; McDonald TO; Trocóniz IF
    Trends Pharmacol Sci; 2020 Nov; 41(11):882-895. PubMed ID: 33032836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions.
    Gross S; Sohl CD
    Biochem Mol Biol Educ; 2021 May; 49(3):407-415. PubMed ID: 33569919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts and challenges in quantitative pharmacology and model-based drug development.
    Zhang L; Pfister M; Meibohm B
    AAPS J; 2008 Dec; 10(4):552-9. PubMed ID: 19003542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R and nlmixr as a gateway between statistics and pharmacometrics.
    Fidler M; Hooijmaijers R; Schoemaker R; Wilkins JJ; Xiong Y; Wang W
    CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):283-285. PubMed ID: 33951757
    [No Abstract]   [Full Text] [Related]  

  • 8. Application and Impact of Human Dose Projection from Discovery to Early Drug Development.
    Patel D; Yang W; Lipert M; Wu T
    AAPS PharmSciTech; 2020 Jan; 21(2):44. PubMed ID: 31897807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aviv Regev.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):256-257. PubMed ID: 33731922
    [No Abstract]   [Full Text] [Related]  

  • 10. Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives.
    Marshall S; Madabushi R; Manolis E; Krudys K; Staab A; Dykstra K; Visser SAG
    CPT Pharmacometrics Syst Pharmacol; 2019 Feb; 8(2):87-96. PubMed ID: 30411538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 12. How to utilize academic research efforts in cancer drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2019 Apr; 14(4):331-334. PubMed ID: 30784328
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet.
    Helmlinger G; Al-Huniti N; Aksenov S; Peskov K; Hallow KM; Chu L; Boulton D; Eriksson U; Hamrén B; Lambert C; Masson E; Tomkinson H; Stanski D
    Eur J Pharm Sci; 2017 Nov; 109S():S39-S46. PubMed ID: 28506868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from Academia to Industry and Back.
    Volkamer A; Riniker S
    J Chem Inf Model; 2018 Aug; 58(8):1469-1472. PubMed ID: 30058337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey.
    Ezzat A; Wu M; Li XL; Kwoh CK
    Brief Bioinform; 2019 Jul; 20(4):1337-1357. PubMed ID: 29377981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.
    Jones HM; Chen Y; Gibson C; Heimbach T; Parrott N; Peters SA; Snoeys J; Upreti VV; Zheng M; Hall SD
    Clin Pharmacol Ther; 2015 Mar; 97(3):247-62. PubMed ID: 25670209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny.
    Corriol-Rohou S; Cheung SYA
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S112-S119. PubMed ID: 31502694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
    Bai JPF; Earp JC; Strauss DG; Zhu H
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491
    [No Abstract]   [Full Text] [Related]  

  • 19. Ophthalmic Drug Discovery and Development.
    Gukasyan HJ; Hailu S; Karami TK
    Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician-Scientist Careers in the Biotechnology and Pharmaceutical Industries.
    Ganem D
    J Infect Dis; 2018 Aug; 218(suppl_1):S20-S24. PubMed ID: 30124980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.